再次心脏手术后Bentall手术的早期结局
单中心1990—2014年473例既往心脏手术后行Bentall手术患者,30天死亡37例(7.8%),主要并发症与手术死亡复合终点152例(32%)。多因素分析显示高龄及非直接吻合的冠状动脉再植入技术是与30天死亡增加相关的危险因素。
要点
- 再次Bentall手术手术风险显著,30天死亡率为7.8%。
- 非直接吻合的冠状动脉再植入技术与不良围术期事件相关。
- 高龄、多次既往心脏手术及术前NYHA III/IV级亦与不良结局相关。
核心结论
- 在既往心脏手术后行Bentall手术的患者中,再次手术与显著的手术风险相关。
- 需要复杂的冠状动脉再植入技术是与不良围术期事件相关的重要因素。
研究设计与样本
- 单中心回顾性队列研究,纳入1990至2014年既往心脏手术后行Bentall手术的473例患者。
- 使用带机械瓣的复合瓣膜移植物256例,带生物瓣的复合瓣膜移植物217例。
- 排除距指标手术不足30天的再次手术患者,主要结局为30天死亡率。
主要发现
- 30天死亡37例(7.8%),主要并发症与手术死亡复合终点152例(32%)。
- 中位年龄57岁(四分位距44-67),男性349例(74%)。
- 指标手术与再次手术中位间隔13年(四分位距8-21)。
- 178例(38%)行紧急或急诊干预,61例(13%)有活动性心内膜炎/脓肿,87例(19%)左心室射血分数低于40%。
- 262例(55%)既往接受过1次以上手术。
关键数值与推荐
- 多因素分析中与30天死亡增加相关的危险因素包括高龄及非直接吻合的冠状动脉再植入技术。
- 间接冠状动脉再植入、既往心脏手术超过1次、术前NYHA功能III/IV级或更差亦与主要并发症和手术死亡复合终点发生率更高相关。
- 再次Bentall时357例(77%)行双冠状动脉直接再植入,79例(17%)至少1支使用间置移植物,26例(5%)至少1支自体冠状动脉缝闭并行静脉旁路移植。
临床怎么用
- 对既往心脏手术后需行Bentall手术者应充分评估手术风险并个体化决策。
- 冠状动脉再植入应尽量采用直接吻合技术,复杂再植入技术需警惕不良围术期事件。
局限性
- 原文摘要未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We sought to evaluate the early outcomes of patients undergoing a Bentall procedure after previous cardiac surgery. METHODS: From 1990 to 2014, 473 patients underwent a Bentall procedure after previous cardiac surgery with a composite valve graft at a single institution: composite valve graft with a mechanical prosthesis (n = 256) or composite valve graft with a bioprosthesis (n = 217). Patients were excluded if their index operation was less than 30 days before the reoperation. The primary outcome was 30-day mortality. The secondary outcome was a composite of major morbidity and operative mortality: stroke, renal failure, prolonged mechanical ventilation, deep sternal infection, or reoperation during the same admission. Multivariable logistic regression was used to identify risk factors associated with the primary and secondary outcomes of interest. RESULTS: Median age was 57 (interquartile range, 44-67) years, and 349 patients (74%) were male. Median time between index surgery and reoperation was 13 (interquartile range, 8-21) years. A total of 178 patients (38%) underwent urgent or emergency intervention, 61 patients (13%) had active endocarditis/abscess, 87 patients (19%) had left ventricular ejection fraction less than 40%, and 262 patients (55%) had undergone more than 1 previous operation. Previous operations (not mutually exclusive) included coronary artery bypass grafting (n = 58, 12%), aortic valve/root replacement (n = 376, 80%) or repair (n = 36, 8%), and other surgical interventions (n = 245, 52%). Ninety-six patients (20%) had undergone coronary reimplantation during the previous operation, which consisted of a Bentall procedure in 81 patients, a Ross operation in 8 patients, a valve-sparing root replacement in 4 patients, and an arterial switch in 3 patients. At the time of the reoperative Bentall, both coronary arteries were reimplanted directly in 357 patients (77%), whereas 79 patients (17%) received at least 1 interposition graft. In 26 patients (5%), at least 1 of the native coronary arteries was oversewn and a vein graft bypass was performed. Thirty-day mortality occurred in 37 patients (7.8%), and 152 patients (32%) had major morbidity and operative mortality. On multivariable analysis, risk factors associated with increased 30-day mortality included older age and coronary reimplantation by a technique other than direct anastomosis. Indirect coronary reimplantation was also associated with a higher incidence of major morbidity and operative mortality, as were more than 1 previous cardiac operation and preoperative New York Heart Association functional class III/IV or greater. CONCLUSIONS: In the largest reported cohort of aortic root replacement after previous cardiac surgery, the reoperative Bentall procedure was associated with a significant operative risk. The need for complex coronary reimplantation techniques was an important factor associated with adverse perioperative events.
引用
- Mazine A, David TE, Lafreniere-Roula M, et al. Early outcomes of the Bentall procedure after previous cardiac surgery. J Thorac Cardiovasc Surg. 2020. PMID: 32387157. doi:10.1016/j.jtcvs.2019.12.134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。